CRISPR Madness: Welcome to the Age of Genetic Chaos
By Stuart A. Newman,
CounterPunch
| 05. 05. 2021
The Nobel prize in chemistry awarded last year to the biochemists Jennifer Doudna and Emmanuelle Charpentier for the genetic modification technique called CRISPR cemented the popular idea that a new era of precision manipulation of hereditary material had arrived. The award came on the heels of the unauthorized use of the technique by the scientist He Jiankui in 2018 in China in an effort to produce individuals (twin girls in this case) resistant to HIV, and a flurry of studies in early 2020 showing that accuracy in altering DNA in a test tube or bacteria in a culture dish, did not hold up when applied to animal embryos. Attempts to modify single genes in human embryos (not intended to be brought to full-term) in fact led to “large-scale, unintended DNA deletions and rearrangements in the areas surrounding the targeted sequence,” aka “genetic chaos.”
Dr. He was imprisoned, fined, and fired from his academic position in China for his actions, although it is still not clear to what extent the higher-ups at his institute were aware of them. At...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...